Global 3D Printed Drugs Market: Current Analysis and Forecast (2020-2027)

  • Single User - $3500
  • Multi User - $4900
  • Enterprise User - $6860
  • Buy Report

3D printed drugs are gaining popularity on account of their benefits to not only the consumer but also to the drug/ pharma manufacturing companies. The drugs manufacturing companies are inclined and adopting additive manufacturing technology to their production unit for purposes such as reduce costs, mass production, and personalized medicine as well. Moreover, 3D printed drugs are driving the pharmaceutical industry towards personalized medicine. Moreover, the surging prevalence of dysphagia is contributing to the growing demand for the personalized medicines. In the general population of 29 years to 32 years, the prevalence of dysphagia is around 16-23% which is increasing to 27% in those over 76 years of age. Also, 50% of people have difficulties during pill intake, As revealed by PMLiVE. The difficulty in pill intake is because of the size and shape of the medicine. Therefore, companies had started producing personalized medicine in different sizes, shapes, and dosage. The government across the countries are investing in 3D printing projects. In 2020, the government of Australia along with and the state of Lower Austria have launched two funding packages for digital technologies including 3D printing. Also, the government of the United Kingdom invested USD 920.40 in 2010 for technologies including 3D printing as well. Also, the COVID-19 pandemic gave a robust growth to the 3D printed drugs market owing to the shortage of medicine. As per the U.S National Library of Medicine National Institute of Health, Medication shortages in 2020 have reached 87% that of the shortages reported in 2019 in half of the time. Based on the technology, the 3D printed drugs market is bifurcated into Inkjet printing, Fused deposition modeling, Stereolithography, and others. The Inkjet printing segment generated revenue of US$ 269.7 million in 2019. The market for the Inkjet printing segment is expected to grow at a CAGR of 16.6% during the forecast period to reach a market valuation of US$ 954.1 million by 2027. However, Stereolithography Market is expected to witness substantial growth during the forecast period 2021-2027. Based on the application type, the 3D printed drugs market is fragmented into Orthopedic, Neurology, Hearing & Audibility Aid, Medical Implants, Dental, and Others. The neurology segment generated revenue of US$ 224.2 million in 2019. The market is expected to grow at a CAGR of 16.2% during the forecast period to reach a market valuation of US$ 775.7 million by 2027. Based on drug form, the 3D printed drugs market is fragmented into Tablet, Capsules, Multi-Drug Implants, Nanoparticles, Solutions, Nano Suspension, Encapsulated within a polymer and Implant. The Tablet segment generated revenue of US$ 190.5 million in 2019. The market is expected to grow at a CAGR of 16.3% during the forecast period to reach a market valuation of US$ 663.4 million by 2027. Based on the drug, the 3D printed drugs market is fragmented into Spritam and Others. The Spritam segment generated revenue of US$ 416.3 million in 2019. The market is expected to grow at a CAGR of 12.8% during the forecast period to reach a market valuation of US$ 1142.9 million by 2027. However, the other segment would proliferate with the highest CAGR during the forthcoming years. Based on end-users, the 3D printed drugs market is fragmented into Hospitals, Clinics, and Research Laboratories. The hospital segment generated revenue of US$ 204.8 million in 2019. The market is expected to grow at a CAGR of 15.6 % during the forecast period to reach a market valuation of US$ 680.7 billion by 2027. However, the research laboratories segment is expected to witness the highest CAGR during the forecast period. For a better understanding of the market penetration of 3D printed drugs, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South-Korea, and Rest of Asia-Pacific), and Rest of the world. North America constitutes a major market for 3D printed medicine. Some of the major players operating in the market include Aprecia Pharmaceuticals, LLC., GlaxoSmithKline plc, AstraZeneca, FabRx Ltd., Hewlett Packard Caribe, Merck KGaA, Cycle Pharmaceuticals, and Tvasta. The global 3D printed drugs market was valued at US$ 638.6 million in 2019 and is projected to expand significantly with a CAGR of 15.24 % from 2021 to 2027. The global 3D printed drugs market is expected to witness a boost, owing to the surging prevalence of dysphagia, rising investment in healthcare technologies, and the surging demand for the personalized medicines.

1 MARKET INTRODUCTION 1.1 Market Definitions 1.2 Objective of the Study 1.3 Limitation 1.4 Stake Holders 1.5 Currency Used in Report 1.6 Scope of the Global 3D Printed Drugs Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1 Research Methodology for the Global 3D Printed Drugs Market 2.1.1 Main Objective of the Global 3D Printed Drugs Market 3 INDUSTRY PERFORMANCE 4 EXECUTIVE SUMMARY 5 CASE STUDIES 6 COVID-19 IMPACT 7 MARKET INSIGHTS BY TECHNOLOGY 7.1 Inkjet Printing 7.2 Fused Deposition Modelling 7.3 Stereolithography 7.4 Others 8 MARKET INSIGHTS BY APPLICATION 8.1 Orthopaedic 8.2 Neurology 8.3 Hearing & Audibility Aid 8.4 Medical Implants 8.5 Dental 8.6 Others 9 MARKET INSIGHTS BY DRUG FORM 9.1 Tablets 9.2 Capsules 9.3 Multi Drug Implants 9.4 Nano Particles 9.5 Solutions 9.6 Nano Suspension 9.7 Encapsulated within a Polymer 9.8 Implant 10 MARKET INSIGHTS BY DRUG 10.1 Spritam 10.2 Others 11 MARKET INSIGHTS BY END-USER 11.1 Hospitals 11.2 Clinics 11.3 Research Laboratories 12 MARKET INSIGHTS BY REGION 12.1 North America 3D Printed Drugs Market 12.1.1 US 12.1.2 Canada 12.1.3 Rest of North America 12.2 Europe 3D Printed Drugs Market 12.2.1 United Kingdom 12.2.2 France 12.2.3 Germany 12.2.4 Spain 12.2.5 Italy 12.2.6 Rest of Europe 12.3 Asia Pacific 3D Printed Drugs Market 12.3.1 China 12.3.2 India 12.3.3 Japan 12.3.4 Australia 12.3.5 South Korea 12.3.6 Rest of Asia Pacific 12.4 Rest of the World 3D Printed Drugs Market 13 3D PRINTED DRUGS MARKET DYNAMICS 13.1 Market Drivers 13.2 Market Challenges 13.3 Impact Analysis 14 LEGAL & REGULATORY FRAMEWORK 15 DEMAND AND SUPPLY SIDE ANALYSIS 15.1 Demand Side Analysis 15.2 Supply Side Analysis 15.2.1 Top Product Launches 15.2.2 Top Business Partnerships 15.2.3 Top Merger & Acquisitions 15.2.4 Top Business Expansions and Investments 16 VALUE CHAIN ANALYSIS 17 3D PRINTED DRUGS MARKET HOTSPOT & OPPORTUNITIES 18 3D PRINTED DRUGS MARKET TRENDS & INSIGHTS 19 COMPETITIVE SCENARIO 19.1 Porter’s Five forces analysis 19.1.1 Bargaining power of Supplier 19.1.2 Bargaining power of Buyer 19.1.3 Industry Rivalry 19.1.4 Availability of Substitute 19.1.5 Threat of new Entrants 19.2 Competitive Landscape 19.2.1 Company Shares, By Revenue 19.3 Competition Matrix 19.3.1 Product/Service Portfolio 19.3.2 Target Markets 19.3.3 Target End Users 19.3.4 Research and Developments    19.3.5 Strategic Alliances 20 COMPANY PROFILED 20.1 Aprecia Pharmaceuticals, LLC 20.1.1 Key Facts 20.1.2 Business Description 20.1.3 Key Product/Services Offerings 20.1.4 Growth Strategy 20.1.5 SWOT Analysis 20.1.6 Key Financials 20.1.6.1 20.1.6.2 20.1.7 Recent Developments 20.1.7.1 20.1.7.2 20.1.7.3 20.1.7.4 20.2 GlaxoSmithKline plc 20.3 AstraZeneca 20.4 FabRx Ltd 20.5 Hewlett Packard Caribe 20.6 Merck KGaA 20.7 Cycle Pharmaceuticals 20.8 Tvasta 21    DISCLAIMER

Related Reports

Protein Engineering Market Forecast till 2027

Protein Engineering Market: Information by Type (Instrument, Reagent, Services & Software), by Application (Food & Detergent Industries, Environmental, Medical, Biopolymer Production, Nano Biotechnology), by Method (Rational Protein Design and Directed Evoluti ... read more

Category: Pharmaceuticals and Healthcare
Published: Jan 2022
Pages: 132
Single user Price: $4450
Epilepsy Surgery Market Forecast till 2027

Epilepsy Surgery Market: Information by Procedure Type (Resective Surgery, Laser Interstitial Thermal Therapy (LITT),), by End User (Hospitals & Clinics, Specialty Centers) and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast til ... read more

Category: Pharmaceuticals and Healthcare
Published: Jan 2022
Pages: 105
Single user Price: $4450
Disposable Nitrile Gloves Market Forecast 2027

Disposable Nitrile Gloves Market: Information by Type (Powder-free and Powdered), by Application (Medical and Non-medical), and by Region(Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2027 Market Overview The global disposable ... read more

Category: Pharmaceuticals and Healthcare
Published: Jan 2022
Pages: 91
Single user Price: $4450
Global Dental Software Market Forecast till 2027

Dental Software Market: Information by Type (Practice Management Software, Patient Communication Software, Treatment Planning Software, Patient Education Software, Dental Imaging Software), by Deployment (On-Premise, Web-Based, Cloud-Based), by End User (Denta ... read more

Category: Pharmaceuticals and Healthcare
Published: Jan 2022
Pages: 120
Single user Price: $4450
Global Dental industry Market Research Report—Forecast till 2027

Market Synopsis:
Global Dental Industry Market is anticipated to exhibit a CAGR of 5.28% during the forecast period of 2020 to 2027, to surpass USD 42,244.27 Million by 2027. The increasing dental caries in children and adults are expected to drive t ... read more

Category: Pharmaceuticals and Healthcare
Published: Jan 2022
Pages: 490
Single user Price: $4450